Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2089207Generated: October 30, 2026

4-(2-Ethyl-thiazol-5-yl)-4-hydroxy-cyclohexanone → N-{1-[4-(2-Ethyl-thiazol-5-yl)-4-hydroxy-cyclohexyl]-azetidin-3-yl}-2-[1-(2,2,2-trifluoro-ethyl)-5-trifluoromethyl-1H-indazol-3-ylamino]-acetamide

https://huagongshe.com/reaction/2089207

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-(2-Ethyl-thiazol-5-yl)-4-hydroxy-cyclohexanoneHCID 59361558—
ReactantN-(azetidin-3-yl)-2-((1-(2,2,2-trifluoroethyl)-5-(trifluoromethyl)-1H-indazol-3-yl)amino)acetamide TFA saltHCID 86660182—
ProductN-{1-[4-(2-Ethyl-thiazol-5-yl)-4-hydroxy-cyclohexyl]-azetidin-3-yl}-2-[1-(2,2,2-trifluoro-ethyl)-5-trifluoromethyl-1H-indazol-3-ylamino]-acetamideHCID 54755677—

Reaction Steps

The title compound was prepared as a white solid from reaction of N-(azetidin-3-yl)-2-((1-(2,2,2-trifluoroethyl)-5-(trifluoromethyl)-1H-indazol-3-yl)amino)acetamide TFA salt (as prepared in Example 72, Step A) and 4-(2-ethyl-thiazol-5-yl)-4-hydroxy-cyclohexanone using the procedure described in Step E of Example 1.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08436023B2
Source datasetuspto-grants-2013_05
ORD IDord-53ccf7e5b0bc4a0cb5ef0f9685dd6f54
Source noteuspto-grants-2013_05